跳至主要内容
临床试验/NL-OMON54891
NL-OMON54891已完成不适用

Pulmonary damage after hospitalization for acute COVID-19, an exploratory prospective cohort study. - Pulmonary damage after acute COVID-19.

Radboud Universitair Medisch Centrum0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patients eligible for post-COVID-19 care program
  • 2. Written informed consent from patient or legal representative
  • 3. CT during admission with CO-RADS ><= 3 or Laboratory confirmed (PRC of
  • serologic) diagnosis of COVID-19

排除标准

  • 1. Age <18 years
  • 2. Pregnancy
  • 3. Subjects with a history of allergy or intolerance to iodinated intravenous
  • contrast media
  • 4. Subjects with pre-existent severe renal impairment (creatinine clearance
  • less than 30 mL/min/1.73m^2)
  • 5. Subjects using therapeutic anticoagulation

研究者

相似试验